Search by Drug Name or NDC

    NDC 00904-6255-49 Sore Throat Logenzes 15; 3.6 mg/1; mg/1 Details

    Sore Throat Logenzes 15; 3.6 mg/1; mg/1

    Sore Throat Logenzes is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is BENZOCAINE; MENTHOL.

    Product Information

    NDC 00904-6255
    Product ID 0904-6255_09bcb3ce-0646-291e-e063-6294a90aef73
    Associated GPIs 88359902154795
    GCN Sequence Number 067735
    GCN Sequence Number Description benzocaine/menthol LOZENGE 15MG-3.6MG MUCOUS MEM
    HIC3 H0A
    HIC3 Description LOCAL ANESTHETICS
    GCN 30354
    HICL Sequence Number 001675
    HICL Sequence Number Description BENZOCAINE/MENTHOL
    Brand/Generic Generic
    Proprietary Name Sore Throat Logenzes
    Proprietary Name Suffix Sore Throat
    Non-Proprietary Name Benzocaine and Menthol
    Product Type HUMAN OTC DRUG
    Dosage Form LOZENGE
    Route ORAL
    Active Ingredient Strength 15; 3.6
    Active Ingredient Units mg/1; mg/1
    Substance Name BENZOCAINE; MENTHOL
    Labeler Name Major Pharmaceuticals
    Pharmaceutical Class Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M013
    Listing Certified Through 2024-12-31

    Package

    NDC 00904-6255-49 (00904625549)

    NDC Package Code 0904-6255-49
    Billing NDC 00904625549
    Package 18 BLISTER PACK in 1 CARTON (0904-6255-49) / 18 LOZENGE in 1 BLISTER PACK
    Marketing Start Date 2012-12-28
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.15622
    Pricing Unit EA
    Effective Date 2023-11-22
    NDC Description SORE THROAT 15-3.6 MG LOZENGE
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis